ReP USP - Resultado da busca

Artigo de periodico
Genome-wide and candidate genes approach for pharmacogenomics of atorvastatin (2009)
Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki
Source: Clinica Lipidology. Unidade: FCF
Subjects: DOENÇAS CARDIOVASCULARES, HIPERCOLESTEROLEMIA, FARMACOGENÉTICA, GENOMAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HIRATA, Rosario Dominguez Crespo e HIRATA, Mario Hiroyuki. Genome-wide and candidate genes approach for pharmacogenomics of atorvastatin. Clinica Lipidology, v. 4, n. 4, p. 419-423, 2009Tradução . . Disponível em: https://doi.org/10.2217/clp.09.32. Acesso em: 30 jun. 2024.
APA
Hirata, R. D. C., & Hirata, M. H. (2009). Genome-wide and candidate genes approach for pharmacogenomics of atorvastatin. Clinica Lipidology, 4( 4), 419-423. doi:10.2217/clp.09.32
NLM
Hirata RDC, Hirata MH. Genome-wide and candidate genes approach for pharmacogenomics of atorvastatin [Internet]. Clinica Lipidology. 2009 ; 4( 4): 419-423.[citado 2024 jun. 30 ] Available from: https://doi.org/10.2217/clp.09.32
Vancouver
Hirata RDC, Hirata MH. Genome-wide and candidate genes approach for pharmacogenomics of atorvastatin [Internet]. Clinica Lipidology. 2009 ; 4( 4): 419-423.[citado 2024 jun. 30 ] Available from: https://doi.org/10.2217/clp.09.32
Artigo de periodico
Statin regulation of CYP3A4 and CYP3A5 expression (2009)
Willrich, Maria Alice Vieira; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Source: Pharmacogenomics. Unidade: FCF
Subjects: FARMACOGENÉTICA, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WILLRICH, Maria Alice Vieira e HIRATA, Mario Hiroyuki e HIRATA, Rosario Dominguez Crespo. Statin regulation of CYP3A4 and CYP3A5 expression. Pharmacogenomics, v. 10, n. 6, p. 1017-1024, 2009Tradução . . Disponível em: https://doi.org/10.2217/pgs.09.42. Acesso em: 30 jun. 2024.
APA
Willrich, M. A. V., Hirata, M. H., & Hirata, R. D. C. (2009). Statin regulation of CYP3A4 and CYP3A5 expression. Pharmacogenomics, 10( 6), 1017-1024. doi:10.2217/pgs.09.42
NLM
Willrich MAV, Hirata MH, Hirata RDC. Statin regulation of CYP3A4 and CYP3A5 expression [Internet]. Pharmacogenomics. 2009 ; 10( 6): 1017-1024.[citado 2024 jun. 30 ] Available from: https://doi.org/10.2217/pgs.09.42
Vancouver
Willrich MAV, Hirata MH, Hirata RDC. Statin regulation of CYP3A4 and CYP3A5 expression [Internet]. Pharmacogenomics. 2009 ; 10( 6): 1017-1024.[citado 2024 jun. 30 ] Available from: https://doi.org/10.2217/pgs.09.42
Artigo de periodico
Impact of cholesterol on ABC and SLC transporters expression and function and its role in disposition variability to lipid-lowering drugs (2009)
Rodrigues, Alice Cristina ; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Source: Pharmacogenomics. Unidade: FCF
Subjects: LIPOPROTEÍNAS LDL, HIPERCOLESTEROLEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RODRIGUES, Alice Cristina e HIRATA, Mario Hiroyuki e HIRATA, Rosario Dominguez Crespo. Impact of cholesterol on ABC and SLC transporters expression and function and its role in disposition variability to lipid-lowering drugs. Pharmacogenomics, v. 10, n. 6, p. 1007-1016, 2009Tradução . . Disponível em: https://doi.org/10.2217/pgs.09.18. Acesso em: 30 jun. 2024.
APA
Rodrigues, A. C., Hirata, M. H., & Hirata, R. D. C. (2009). Impact of cholesterol on ABC and SLC transporters expression and function and its role in disposition variability to lipid-lowering drugs. Pharmacogenomics, 10( 6), 1007-1016. doi:10.2217/pgs.09.18
NLM
Rodrigues AC, Hirata MH, Hirata RDC. Impact of cholesterol on ABC and SLC transporters expression and function and its role in disposition variability to lipid-lowering drugs [Internet]. Pharmacogenomics. 2009 ; 10( 6): 1007-1016.[citado 2024 jun. 30 ] Available from: https://doi.org/10.2217/pgs.09.18
Vancouver
Rodrigues AC, Hirata MH, Hirata RDC. Impact of cholesterol on ABC and SLC transporters expression and function and its role in disposition variability to lipid-lowering drugs [Internet]. Pharmacogenomics. 2009 ; 10( 6): 1007-1016.[citado 2024 jun. 30 ] Available from: https://doi.org/10.2217/pgs.09.18
Artigo de periodico
ABCA1 expression and statins: inhibitory effect in peripheral blood mononuclear cells (2009)
Genvigir, Fabiana Dalla Vecchia; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Source: Pharmacogenomics. Unidade: FCF
Subjects: EXPRESSÃO GÊNICA, LIPOPROTEÍNAS LDL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GENVIGIR, Fabiana Dalla Vecchia e HIRATA, Mario Hiroyuki e HIRATA, Rosario Dominguez Crespo. ABCA1 expression and statins: inhibitory effect in peripheral blood mononuclear cells. Pharmacogenomics, v. 10, n. 6, p. 997-1005, 2009Tradução . . Disponível em: https://doi.org/10.2217/pgs.09.30. Acesso em: 30 jun. 2024.
APA
Genvigir, F. D. V., Hirata, M. H., & Hirata, R. D. C. (2009). ABCA1 expression and statins: inhibitory effect in peripheral blood mononuclear cells. Pharmacogenomics, 10( 6), 997-1005. doi:10.2217/pgs.09.30
NLM
Genvigir FDV, Hirata MH, Hirata RDC. ABCA1 expression and statins: inhibitory effect in peripheral blood mononuclear cells [Internet]. Pharmacogenomics. 2009 ; 10( 6): 997-1005.[citado 2024 jun. 30 ] Available from: https://doi.org/10.2217/pgs.09.30
Vancouver
Genvigir FDV, Hirata MH, Hirata RDC. ABCA1 expression and statins: inhibitory effect in peripheral blood mononuclear cells [Internet]. Pharmacogenomics. 2009 ; 10( 6): 997-1005.[citado 2024 jun. 30 ] Available from: https://doi.org/10.2217/pgs.09.30

USP Schools

ReP

Filtros

Subjects

Indexado em